Sun Nuclear Showcases Evolving and Expanding Quality Management Portfolio at ESTRO 2023 Meeting

On Sunday, May 14, Sun Nuclear will hold its annual lunch symposium, featuring insights from leaders in the field of Radiation Therapy. During the symposium, Rhydian Caines, M.Sc., of The Clatterbridge Cancer Centre NHS Foundation Trust (Liverpool, United Kingdom) will present on his centre’s experience using the SunCHECK^® Platform, including highlights from his ESTRO abstract, When no news is good news: commercial automated EPID in vivo dosimetry deployed as a safety check.¹ The abstract aims to demonstrate the effectiveness of the SunCHECK Platform as “an efficient and practical solution for large-scale deployment of IVD [in-vivo dosimetry] as a safety check within a VMAT-first treatment paradigm.”

Featured Solutions
In booth #150, Sun Nuclear will feature comprehensive solutions that address:

• Commissioning and Annual QA: The SunSCAN™ 3D Water Scanning System* simplifies beam scanning with SRS-class accuracy and user-centered design.
• Automated, Integrated Quality Management: The SunCHECK Platform powers Quality Management, with centralized, standardized Patient and Machine QA for Radiation Therapy programs.
• Conventional and Emerging Treatment Modalities: Beyond its gold standard arrays and phantoms, Sun Nuclear offers comprehensive solutions for stereotactic and MR-guided treatment programs, including those with motion management. The work-in-progress MotionCHECK™ 3D for quantifying and assessing target motion and spatial distortions in MR will be on display.
• Diagnostic Imaging QA: Sun Nuclear will also feature highlights for its CT, Ultrasound and Mammography QA portfolios.

The SunCHECK^® Platform will also be featured in the GE HealthCare booth (#1440) at ESTRO, as part of its showcase on interoperability and workflows in Radiation Oncology. The GE HealthCare iRT ecosystem is slated for compatibility with SunCHECK^® Patient software.

“We are eager to share our comprehensive solutions for Quality Management with ESTRO attendees. As our product offerings continue to evolve, from market-leading stereotactic solutions to market redefining solutions like SunCHECK, we further expand our range of solutions to cover more needs for the radiation therapy field,” said Luis Rivera, President of Radiation Therapy QA for Mirion Medical.

To learn more about the featured solutions and talk schedule, visit sunnuclear.com/estro.

In 2022, Sun Nuclear become part of Mirion Medical. ESTRO attendees will notice new branding reflected in the Sun Nuclear booth and the inclusion of CIRS solutions, which are now part of the Sun Nuclear brand.